Literature DB >> 27256718

Tumour lysis syndrome: an unexpected adverse event associated with ipilimumab.

M Masson Regnault1, J Ofaiche1, S Boulinguez1, E Tournier1, P Rochaix2, C Paul1, L Lamant2,3, N Meyer1,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27256718     DOI： 10.1111/jdv.13733

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN： 0926-9959            Impact factor:   6.166


× No keyword cloud information.
  2 in total

1.  Acute Angle Closure Precipitated by Hemorrhage and Necrosis of a Large Uveal Melanoma in the Setting of Systemic Immunomodulatory Therapy.

Authors:  Chau M Pham; Krishna Kalyam; Bradley T Smith; Justin Floyd; John B Holds
Journal:  Ocul Oncol Pathol       Date:  2017-03-24

2.  Tumor Lysis Syndrome following a Single Dose of Nivolumab for Relapsed Small-Cell Lung Cancer.

Authors:  Sarah Maryon Hayes; Christine Wiese; Robert Schneidewend
Journal:  Case Rep Oncol       Date:  2021-11-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.